Robert M. Califf, MD, was sworn in as the new commissioner of the U.S. Food and Drug Administration (FDA) on February 17, 2022.
Previously, Dr. Califf served as FDA commissioner from February 2016–February 2017. Prior to rejoining the FDA, Dr. Califf was head of medical strategy and senior advisor at Alphabet Inc., contributing to strategy and policy for its health subsidiaries, Verily Life Sciences and Google Health. He also served as director of the Duke Translational Medicine Institute and founding director of the Duke Clinical Research Institute.
A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, health-care quality, and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,300 publications in the peer-reviewed literature.
Dr. Califf will now oversee the federal agency tasked with finalizing and implementing over-the-counter hearing aid regulations.
Recent Posts
CMS Warns of Fraud Scheme
The Centers for Medicare and Medicaid Services (CMS) is warning providers to be on alert for phishing requests to provide Medicare patient information. CMS has…
Nevada Passes Bill to Join ASLP-IC as Legislative Session Closes
On the final day of the Nevada Legislative Session, lawmakers passed Assembly Bill (AB) 230, which was then sent to Governor Joe Lombardo for signature….
MedPAC Report Highlights Key Medicare Policy Shifts Impacting Hearing Health
On June 12, 2025, the Medicare Payment Advisory Commission (MedPAC) delivered its annual June report to Congress, offering critical policy guidance on Medicare payment systems, delivery…